BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 307905)

  • 1. Proof of chymotrypsin activity by a peroral test using a synthetic peptide with a C-terminal P-aminobenzoic acid residue.
    Malis F; Fric P; Kasafírek E; Korbová L; Kohout J
    Acta Univ Carol Med Monogr; 1977; (79 Pt 3):145-8. PubMed ID: 307905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of chymotrypsin labile peptide for a new test of exocrine pancreatic function (PET) in comparison and pancreozymin-secretin test.
    Imamura K; Nakamura T; Miyazawa T; Abe Y; Kobayashi M; Takebe K; Toyota T
    Am J Gastroenterol; 1978 May; 69(5):572-8. PubMed ID: 308313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oral test of pancreatic chymotrypsin activity using N-acetyl-L-tyrosyl-p-amino-benzoic acid in rats.
    Malis F; Fric EK; Korbová L
    J Clin Chem Clin Biochem; 1976 Oct; 14(10):499-500. PubMed ID: 1086887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The PABA test].
    Müller G; Biering A; Graubaum K; Jeschkeit H; Neubert K; Kleine R; Klapperstück M
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):219-31. PubMed ID: 6334604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrolysis and metabolism of N-benzoyl-L-tyrosyl-p-aminobenzoic acid in normal and pancreatic duct-ligated animals.
    Yamato C; Kinoshita K
    J Pharmacol Exp Ther; 1978 Aug; 206(2):468-74. PubMed ID: 682127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)].
    Thienhaus R; Niederau C
    Z Gastroenterol; 1979 Mar; 17(3):187-94. PubMed ID: 311979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the estimation of exocrine pancreatic function using p-(N-acetyl-L-tyrosyl)- and p-(N-benzoyl-L-tyrosyl)aminobenzoic acid.
    Malis F; Fric P; Kasafírek E; Slaby J
    Hepatogastroenterology; 1983 Jun; 30(3):99-101. PubMed ID: 6604011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary PABA recovery after oral N-benzoyl-L-tyrosyl-PABA administration combined with various exocrine pancreatic stimulants.
    Cavallini G; Piubello W; Brocco G; Barba E; Baratta S; Dobrilla G; Parolin P; Bonoldi C; Scuro LA
    Hepatogastroenterology; 1980 Jun; 27(3):224-6. PubMed ID: 6970160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of exocrine pancreas function by means of orally administered N-benzoyl-L-tyrosyl-praaminobenzoic acid (BT-PABA-test). Evaluation after 5 years clinical experience].
    Lang C; Gyr K; Borer P; Kayasseh L; Stalder GA
    Schweiz Med Wochenschr; 1980 Apr; 110(14):522-8. PubMed ID: 6966425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The PABA-peptide test: a method in diagnosis of exocrine pancreatic insufficiency (author's transl)].
    Schneiber E; Burgislaus E
    Med Klin; 1979 Jun; 74(25):1000-3. PubMed ID: 314038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 60-minute blood p-aminobenzoic acid concentration in pancreatic function testing of dogs.
    Strombeck DR; Harrold D
    J Am Vet Med Assoc; 1982 Feb; 180(4):419-21. PubMed ID: 6977519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of the oral NBT-PABA test for the diagnosis of chronic pancreatitis].
    Meyer B; Gyr K
    Leber Magen Darm; 1987 Oct; 17(5):334-8. PubMed ID: 3500382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum paraaminobenzoic acid following the use of N-benzoyl-L-tyrosyl-paraaminobenzoic acid in the diagnosis of pancreatic insufficiency].
    Wolf C; Ehrig C; Brunner H
    Schweiz Med Wochenschr; 1981 Mar; 111(10):343-7. PubMed ID: 6971491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method of testing pancreatin therapy in vivo by the use of a peroral chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid.
    Fric P; Malis F; Kasafírek E; Slabý J
    Hepatogastroenterology; 1980 Jun; 27(3):220-3. PubMed ID: 6970159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study of exocrine pancreatic function test by oral administration by N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
    Kimura T; Wakasugi H; Ibayashi H
    Digestion; 1981; 21(3):133-9. PubMed ID: 7011889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First experiences with a new oral human pancreas function test with special emphasis on gastric voiding].
    Gyr K; Schiffmann I; Fehr C; Vonderschmitt D; Fridrich R; Locher I
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1717-8. PubMed ID: 1215965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Ac-L-Tyr-PAB for estimating the activity of chymotrypsin in rats.
    Jaczewska A; Pastuszewska B; Bartik M; Kowalczyk J
    Acta Physiol Pol; 1982; 33(4):361-8. PubMed ID: 6985185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proof of pancreatic chymotrypsin activity in rats using the synthetic peptide peroral test with C-terminal residuum of p-aminobenzoic acid (PBA) (author's transl)].
    Malis F; Kasafírek E; Fric P; Korbová L
    Cas Lek Cesk; 1975 Aug; 114(33):1021-2. PubMed ID: 1164720
    [No Abstract]   [Full Text] [Related]  

  • 20. A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests.
    Lami F; Callegari C; Miglioli M; Barbara L
    Am J Gastroenterol; 1984 Sep; 79(9):697-700. PubMed ID: 6332529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.